Medscape Medical News - FDA Approvals
- Alert FDA Approves JAK Inhibitor for Alopecia Areata
- Alert Two Soliris Biosimilars Approved for PNH in the United States
- Alert FDA OKs Voquezna for Heartburn Relief in Nonerosive GERD
- Alert FDA Approves Topical Eczema Rx for Ages 6 or Older
- Philips Issues Update on Ventilator Alarm Failure
- Alert FDA Approves Donanemab for Early Alzheimer's
- Alert FDA Approves Third Ustekinumab Biosimilar
- Alert FDA Approves Epcoritamab for R/R Follicular Lymphoma
- Alert FDA Approves New Treatment for Excessive Underarm Sweating
- Alert FDA OKs Vyvgart Hytrulo for CIDP
- Alert FDA Approves Adagrasib for KRAS G12C–Mutated CRC
- Alert FDA Approves Skyrizi for Ulcerative Colitis
- Alert New Pneumococcal Vaccine Approved
- Alert FDA Expands Pembrolizumab Approval for Endometrial Cancer
- Alert Blincyto Picks Up New BCP-ALL Indication
- Alert FDA Expands Durvalumab Label to Endometrial Cancer
- Alert FDA Expands Repotrectinib Label
- Alert FDA OKs Sarilumab for Polyarticular JIA
- Alert FDA OKs Iqirvo, First-in-Class PPAR Treatment for PBC
- Alert FDA Approves Expansion of Treatment Area for AK Treatment